Literature DB >> 19358827

Crystal structures of free and ligand-bound focal adhesion targeting domain of Pyk2.

James Lulo1, Satoru Yuzawa, Joseph Schlessinger.   

Abstract

Focal adhesion targeting (FAT) domains target the non-receptor tyrosine kinases FAK and Pyk2 to cellular focal adhesion areas, where the signaling molecule paxillin is also located. Here, we report the crystal structures of the Pyk2 FAT domain alone or in complex with paxillin LD4 peptides. The overall structure of Pyk2-FAT is an antiparallel four-helix bundle with an up-down, up-down, right-handed topology. In the LD4-bound FAT complex, two paxillin LD4 peptides interact with two opposite sides of Pyk2-FAT, at the surfaces of the alpha1alpha4 and alpha2alpha3 helices of each FAT molecule. We also demonstrate that, while paxillin is phosphorylated by Pyk2, complex formation between Pyk2 and paxillin does not depend on Pyk2 tyrosine kinase activity. These experiments reveal the structural basis underlying the selectivity of paxillin LD4 binding to the Pyk2 FAT domain and provide insights about the molecular details which influence the different behavior of these two closely-related kinases.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19358827     DOI: 10.1016/j.bbrc.2009.04.011

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  20 in total

1.  Molecular recognition of leucine-aspartate repeat (LD) motifs by the focal adhesion targeting homology domain of cerebral cavernous malformation 3 (CCM3).

Authors:  Xiaofeng Li; Weidong Ji; Rong Zhang; Ewa Folta-Stogniew; Wang Min; Titus J Boggon
Journal:  J Biol Chem       Date:  2011-06-01       Impact factor: 5.157

2.  Structural basis of the target-binding mode of the G protein-coupled receptor kinase-interacting protein in the regulation of focal adhesion dynamics.

Authors:  Mingfu Liang; Xingqiao Xie; Jian Pan; Gaowei Jin; Cong Yu; Zhiyi Wei
Journal:  J Biol Chem       Date:  2019-02-08       Impact factor: 5.157

3.  Crystal structure of CCM3, a cerebral cavernous malformation protein critical for vascular integrity.

Authors:  Xiaofeng Li; Rong Zhang; Haifeng Zhang; Yun He; Weidong Ji; Wang Min; Titus J Boggon
Journal:  J Biol Chem       Date:  2010-05-19       Impact factor: 5.157

Review 4.  Focal adhesion kinase regulation of mechanotransduction and its impact on endothelial cell functions.

Authors:  Noureddine Zebda; Oleksii Dubrovskyi; Konstantin G Birukov
Journal:  Microvasc Res       Date:  2011-06-29       Impact factor: 3.514

Review 5.  Targeting FAK in anticancer combination therapies.

Authors:  John C Dawson; Alan Serrels; Dwayne G Stupack; David D Schlaepfer; Margaret C Frame
Journal:  Nat Rev Cancer       Date:  2021-03-17       Impact factor: 60.716

6.  FAK dimerization controls its kinase-dependent functions at focal adhesions.

Authors:  Karen Brami-Cherrier; Nicolas Gervasi; Diana Arsenieva; Katarzyna Walkiewicz; Marie-Claude Boutterin; Alvaro Ortega; Paul G Leonard; Bastien Seantier; Laila Gasmi; Tahar Bouceba; Gress Kadaré; Jean-Antoine Girault; Stefan T Arold
Journal:  EMBO J       Date:  2014-01-30       Impact factor: 11.598

7.  The Pyk2 FERM regulates Pyk2 complex formation and phosphorylation.

Authors:  Daniel Riggs; Zhongbo Yang; Jean Kloss; Joseph C Loftus
Journal:  Cell Signal       Date:  2010-09-16       Impact factor: 4.315

Review 8.  FAK in cancer: mechanistic findings and clinical applications.

Authors:  Florian J Sulzmaier; Christine Jean; David D Schlaepfer
Journal:  Nat Rev Cancer       Date:  2014-08-07       Impact factor: 60.716

Review 9.  Targeting Pyk2 for therapeutic intervention.

Authors:  Christopher A Lipinski; Joseph C Loftus
Journal:  Expert Opin Ther Targets       Date:  2010-01       Impact factor: 6.902

10.  Structural and mechanistic insights into the interaction between Pyk2 and paxillin LD motifs.

Authors:  Murugendra S Vanarotti; Darcie J Miller; Cristina D Guibao; Amanda Nourse; Jie J Zheng
Journal:  J Mol Biol       Date:  2014-08-29       Impact factor: 5.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.